RE: Correlational of oral tongue cancer inversion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression, by Kim S-H, Cho NH, Kim K, et al.

Journal of Histotechnology

Volumn 28, Issue 4, 2005, Pages 253-254

  Lim, Megan S ^a,b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; VASCULOTROPIN; VASCULOTROPIN A; CD31 ANTIGEN; MONOCLONAL ANTIBODY; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN;

ANGIOGENESIS; CANCER INVASION; CANCER STAGING; EDITORIAL; HUMAN; METASTASIS; MOUTH CANCER; TONGUE CANCER; ANIMAL; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NOTE; PATHOLOGY; PROGNOSIS; TONGUE TUMOR; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MICE; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TONGUE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645062960     PISSN: 01478885     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20462     Document Type: Editorial

References (11)

1. Rundhaug JE: Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005;9:267-285.
2. Arbeit JM: Transgenic models of epidermal neoplasia and multistage carcinogenesis. Cancer Surv 1996;26:7-34.
3. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15-18.
4. O'Reilly MS, Boehra T, Shing Y, et al.: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-285.
5. Sauter ER, Nesbit M, Watson JC, et al.: Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 1999;5:775-782.
6. Edwards DR, Beaudry PP, Laing TD, et al.: The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes Relat Metab Disord 1996;20:S9-S15.
7. Wang H, Keiser JA: Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1. Circ Res 1998;83:832-840.
8. Zaman K, Driscoll R, Hahn D, et al.: Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy. Int J Cancer 2006;118:755-764.
9. Hahn CN, Su ZJ, Drogemuller CJ, et al.: Expression profiling reveals functionally important genes and coordinately regulated signaling pathway genes during in vitro angiogenesis. Physiol Genomics 2005;22:57-69.
10. Karsan A, Pollet I, Yu LR, et al.: Quantitative proteomic analysis of sokotrasterol sulfate-stimulated primary human endothelial cells. Mol Cell Proteomics 2005;4:191-204.
11. Zakarija A, Soff G: Update on angiogenesis inhibitors. Curr Opin Oncol 2005;17:578-583.